COGNITION THERAPEUTICS INC — Director's Dealing 2021

Oct 8, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-10-07

Reporting Person: O'Brien James Michael (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.07	2029-10-07	Common Stock (130931)		Direct

Footnotes

F1: 25% of the shares underlying the option vest on the first anniversary of the option's grant date and the remaining 75% vest in equal monthly installments for the thirty-six (36) months thereafter. The option was granted on October 7, 2019.